Stocklytics Platform
Asset logo for symbol IMRX
Immuneering Corporation
Penny Stock
Asset logo for symbol IMRX



AI Deep-Learning Forecast (IMRX)

Analyst Forecast

Period: Next 12 Months

Analyst Ratings

Immuneering Corporation (IMRX) Stocklytics Forecast

The stock price prediction for Immuneering Corporation (IMRX) is a topic of interest among investors and analysts. With the company's innovative approach to drug discovery using bioinformatics and computational biology, there is a lot of potential for growth in the future. AI and machine learning algorithms can be used to make price predictions based on historical data and trends in the biotech industry. These predictions can help investors make informed decisions about buying or selling IMRX stocks. In 2023, the stock price of IMRX is expected to continue its upward trajectory as the company expands its product pipeline and gains regulatory approvals for its drugs. Analysts have set a price target for IMRX at $50 by 2023, indicating a significant upside potential. With positive analyst ratings and a promising future outlook, IMRX stock is considered a good buy for investors seeking long-term growth.

Immuneering Corporation (IMRX) has been receiving favorable analyst ratings, further boosting investor confidence. Analysts have recognized the company's potential to revolutionize the biotech industry with its bioinformatics and computational biology expertise. The stock price forecast for IMRX is optimistic, with projections suggesting substantial growth in the coming years. By leveraging AI and machine learning algorithms, analysts have predicted that IMRX stock could reach a price target of $50 by 2023. This target reflects the company's strong product pipeline, potential regulatory approvals, and overall positive market sentiment. With the analysts' favorable price targets and the company's innovative approach, IMRX stock is considered an attractive investment opportunity for long-term investors.

add Immuneering Corporation to watchlist

Keep an eye on Immuneering Corporation

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

What is the analyst price prediction for Immuneering Corporation (IMRX) stock?

Analysts have set a target price of $16.83 for Immuneering Corporation (IMRX), based on forecasts from 24 analysts. The predicted price range extends from a high of $25 to a low of $3. This represents a potential increase of up to 1.92K% and a decrease of 141.94% from the current price of $1.24. These forecasts are as of 2021 Aug 24.

What are the analyst ratings for Immuneering Corporation (IMRX) stock?

Currently, there are no analyst ratings available for Immuneering Corporation (IMRX), possibly due to insufficient coverage or recent updates.

What is the AI price prediction for Immuneering Corporation (IMRX) stock?

At present, there is no AI or machine-learning-based price prediction available for Immuneering Corporation (IMRX) stock. The lack of a forecast could stem from various factors, such as inadequate data or the necessity for model recalibration.


Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Take Your Investments to a Whole New Level